Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
GKOS
Stock Latest News
Company Announcements
Glaukos Corp. Reports Record Sales and FDA Approval
1d ago
GKOS
Premium
The Fly
Midday Fly By: Big Tech reports, Novo tops Pfizer bid for Metsera
1d ago
BA
CI
Premium
The Fly
Glaukos rises 27.5%
1d ago
GKOS
Premium
The Fly
Glaukos price target raised to $120 from $110 at JPMorgan
2d ago
GKOS
Premium
The Fly
Glaukos price target raised to $113 from $110 at Citi
2d ago
GKOS
Premium
The Fly
Glaukos price target raised to $116 from $104 at BTIG
2d ago
GKOS
Premium
Ratings
Cautious Outlook for Glaukos Amid Regulatory Uncertainty and Valuation Concerns
2d ago
GKOS
Premium
The Fly
Glaukos price target raised to $122 from $120 at Wells Fargo
2d ago
GKOS
Premium
Ratings
Strong Buy Rating for Glaukos Driven by iDose Success and Positive Revenue Projections
2d ago
GKOS
Premium
Ratings
Glaukos’s Strong Growth Prospects: Buy Rating Affirmed Amid Surpassing Sales and Promising Pipeline
2d ago
GKOS
Premium
Company Announcements
Glaukos Corp. Reports Record Q3 Sales Growth
2d ago
GKOS
Premium
The Fly
Closing Bell Movers: Meta sinks, Alphabet jumps after earnings
2d ago
GH
PI
Premium
Company Announcements
Glaukos Reports Record Q3 2025 Sales Growth
2d ago
8K
GKOS
Premium
The Fly
Glaukos reports Q3 EPS (16c), consensus (26c)
2d ago
GKOS
Premium
The Fly
Glaukos sees FY25 revenue $490M-$495M, consensus $484.6M
2d ago
GKOS
Premium
The Fly
Glaukos sees FY26 revenue $600M-$620M, consensus $608.1M
2d ago
GKOS
Premium
Company Announcements
Glaukos Corp. Advances NEXAGON® Study for Eye Condition Treatment
4d ago
GKOS
Premium
Company Announcements
Glaukos Corp. Advances in Glaucoma Treatment with New Clinical Trial
4d ago
GKOS
Premium
Company Announcements
Glaukos Corp.’s iDose TR Study: A Potential Game-Changer in Ophthalmic Treatment
4d ago
GKOS
Premium
The Fly
Microsoft upgraded, Harley-Davidson downgraded: Wall Street’s top analyst calls
4d ago
AS
HOG
Premium
The Fly
Wells Fargo upgrades Glaukos on ‘underappreciated’ growth opportunity
5d ago
GKOS
Premium
The Fly
Glaukos upgraded to Overweight from Equal Weight at Wells Fargo
5d ago
GKOS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.